Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

• Egile Nagusiak: Mao S (Egilea), Zhang J (Egilea), Guo Y (Egilea), Zhang Z (Egilea), Wu Y (Egilea), Zhang W (Egilea), Wang L (Egilea), Jiang Geng (Egilea), Yan Y (Egilea), Yao X (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Shiyu Mao,1,* Junfeng Zhang,1,* Yadong Guo,1,* Ziwei Zhang,1 Yuan Wu,2 Wentao Zhang,2 Longsheng Wang,1 Jiang Geng,1 Yang Yan,1 Xudong Yao1 1Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, PR China; 2Department of Urology, Shanghai Tenth People&a...